Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06258551 · ClinicalTrials.gov registry record
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
A clinical trial of Clostridium Difficile and Antibiotic Resistant Infection, sponsored by The Methodist Hospital Research Institute.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT06258551: Recruiting study of Clostridium Difficile and Antibiotic Resistant Infection, sponsored by The Methodist Hospital Research Institute.
NCT06258551 is a study of Clostridium Difficile and Antibiotic Resistant Infection that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 1,000 participants, above the 295-participant average among 6 other Clostridium Difficile trials with a reported enrollment target (239% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06258551, a study of Clostridium Difficile and Antibiotic Resistant Infection, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this observational study is to investigate how bacterial populations from the intestine and mouth of patients change during the hospitalization period and evaluate if some populations of specific bacteria increase or decrease the risk of acquiring an infection or becoming colonized by pathogenic bacteria. Participants will have the following samples collected during enrollment: stool samples (maximum 2x/week), blood draws (1x/week), oral swab (1x/week).
Conditions Studied
Study Locations (2)
Texas
- Houston Methodist Hospital - Houston
- The University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2020-12-08 |
| Est. Completion | 2026-06 |
What NCT06258551 shows while recruiting
NCT06258551 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 295-participant average among 6 other Clostridium Difficile trials with a reported enrollment target (239% higher).
The record links to 8 conditions, with Clostridium Difficile appearing as the primary indexed condition, and to 0 interventions.
NCT06258551 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06258551 about?
NCT06258551 is a clinical study titled "Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients". The goal of this observational study is to investigate how bacterial populations from the intestine and mouth of patients change during the hospitalization period and evaluate if some populations of specific bacteria increase or decrease the risk of acquiring an infection or becoming colonized by pa...
What is the current status of trial NCT06258551?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2020-12-08. Estimated completion is 2026-06.
What conditions does trial NCT06258551 study?
This clinical trial studies the following conditions: Clostridium Difficile, Antibiotic Resistant Infection, Antimicrobial Drug Resistance, Vancomycin Resistant Enterococci Infection, Carbapenem Resistant Bacterial Infection.
Who is sponsoring clinical trial NCT06258551?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06258551 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clostridium Difficile
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
RECRUITING · Phase 3
-
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
ACTIVE NOT RECRUITING
-
SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI)
COMPLETED · Phase 2
-
Dose-Confirmation, Immunogenicity and Safety Study of the Clostridium Difficile Vaccine Candidate VLA84 in Healthy Adults Aged 50 Years and Older. Phase II Study
COMPLETED · Phase 2
-
Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis
COMPLETED · Phase 2
-
Early FMT for C.Difficile
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI